F

Forbius

11 employees

Forbius is a biopharmaceutical company that develops and designs niotherapeutics for the treatment of fibrotic diseases and cancers.

Basic info

Industry

pharmaceutical manufacturing

Sectors

rare diseases
Biotechnology
Health Care
cancer
fibrosis
Pharmaceutical
Pharmaceuticals

Date founded

2011

Funding rounds raised

Total raised

$19M

from 9 investors over 9 rounds

F

Forbius raised $2.5M on October 14, 2019

Investors: HBM Partners AG

F

Forbius raised $19M on August 24, 2018

Investors: Cancer Prevention and Research Institute of Texas

F

Forbius raised $675K on February 2, 2018

Investors: BioCanRx

F

Forbius raised undisclosed on May 15, 2017

Investors: Lumira Ventures

F

Forbius raised undisclosed on September 29, 2014

Investors: Rosseau Asset Management Ltd., Lumira Ventures and MaRS Investment Accelerator Fund

F

Forbius raised undisclosed on April 10, 2012

Investors: Lumira Ventures and Creative Destruction Lab

FAQ